Milton, MA, United States of America

Elaine B Krueger

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 17.1

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Cambridge, MA (US) (2017 - 2019)
  • Milton, MA (US) (2012 - 2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Elaine B. Krueger

Introduction

Elaine B. Krueger, based in Milton, MA, is a notable inventor recognized for her contributions to the field of pharmaceuticals. With a remarkable portfolio of 9 patents, her work primarily focuses on developing innovative solutions for treating health conditions related to kidney disease.

Latest Patents

Among her latest patents is a significant advancement titled “Inhibitors of APOL1 and methods of using same.” This patent discloses various compounds, deuterated derivatives, and pharmaceutically acceptable salts that hold promise in the treatment of APOL1 mediated kidney disease. The innovative nature of her work showcases her commitment to addressing critical health challenges.

Career Highlights

Elaine is affiliated with Vertex Pharmaceuticals, Inc., a company renowned for its dedication to advancing innovative medicines. Throughout her career, she has consistently contributed to the development of groundbreaking treatments, particularly in the realm of kidney disease, making her an influential figure in the pharmaceutical industry.

Collaborations

Elaine has collaborated with distinguished colleagues, including Jon H. Come and Jingrong Cao. These partnerships have fostered a dynamic environment for innovation, allowing her to leverage diverse expertise in her research and development projects.

Conclusion

Elaine B. Krueger stands as a prominent inventor whose work not only enriches the patent landscape but also significantly impacts patients suffering from kidney-related ailments. Her innovative spirit and dedication to research continue to propel advancements in the pharmaceutical industry, marking her as a key player in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…